DE2202176A1 - Komplexe von biologisch aktiven natuerlichen oder synthetischen Peptiden und/oder Polypeptiden und/oder Eiweissstoffen und/oder deren Derivaten bzw. Salzen,pharmazeutische Praeparate mit einem Gehalt an diesen und Verfahren zur Herstellung derselben - Google Patents

Komplexe von biologisch aktiven natuerlichen oder synthetischen Peptiden und/oder Polypeptiden und/oder Eiweissstoffen und/oder deren Derivaten bzw. Salzen,pharmazeutische Praeparate mit einem Gehalt an diesen und Verfahren zur Herstellung derselben

Info

Publication number
DE2202176A1
DE2202176A1 DE19722202176 DE2202176A DE2202176A1 DE 2202176 A1 DE2202176 A1 DE 2202176A1 DE 19722202176 DE19722202176 DE 19722202176 DE 2202176 A DE2202176 A DE 2202176A DE 2202176 A1 DE2202176 A1 DE 2202176A1
Authority
DE
Germany
Prior art keywords
silicon
complexes according
complexes
polypeptides
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722202176
Other languages
German (de)
English (en)
Inventor
Gyoergy Dr Fekete
Istvan Dr Gebhardt
Gyoergy Dr Hajos
Laszlo Dr Szporny
Dr Nagy Geza Takaczsi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE2202176A1 publication Critical patent/DE2202176A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
DE19722202176 1971-01-20 1972-01-18 Komplexe von biologisch aktiven natuerlichen oder synthetischen Peptiden und/oder Polypeptiden und/oder Eiweissstoffen und/oder deren Derivaten bzw. Salzen,pharmazeutische Praeparate mit einem Gehalt an diesen und Verfahren zur Herstellung derselben Pending DE2202176A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (1)

Publication Number Publication Date
DE2202176A1 true DE2202176A1 (de) 1972-08-03

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722202176 Pending DE2202176A1 (de) 1971-01-20 1972-01-18 Komplexe von biologisch aktiven natuerlichen oder synthetischen Peptiden und/oder Polypeptiden und/oder Eiweissstoffen und/oder deren Derivaten bzw. Salzen,pharmazeutische Praeparate mit einem Gehalt an diesen und Verfahren zur Herstellung derselben

Country Status (10)

Country Link
AU (1) AU3784072A (OSRAM)
BE (1) BE778239A (OSRAM)
CA (1) CA972288A (OSRAM)
DD (1) DD98915A5 (OSRAM)
DE (1) DE2202176A1 (OSRAM)
ES (1) ES399033A1 (OSRAM)
FR (1) FR2122529A1 (OSRAM)
IL (1) IL38546A0 (OSRAM)
NL (1) NL7200716A (OSRAM)
ZA (1) ZA72252B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (OSRAM) * 1972-10-12 1981-01-27
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE3230736A1 (de) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht An siliciumdioxid als traeger gebundene wirkstoffe, verfahren zu ihrer herstellung und ihre verwendung
DE3502099A1 (de) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758B1 (fr) * 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation

Also Published As

Publication number Publication date
ZA72252B (en) 1972-09-27
AU3784072A (en) 1973-07-19
NL7200716A (OSRAM) 1972-07-24
DD98915A5 (OSRAM) 1973-07-12
BE778239A (fr) 1972-05-16
FR2122529B1 (OSRAM) 1975-12-26
ES399033A1 (es) 1975-05-16
FR2122529A1 (en) 1972-09-01
CA972288A (en) 1975-08-05
IL38546A0 (en) 1972-03-28

Similar Documents

Publication Publication Date Title
DE60033437T2 (de) Glp-2 enthaltende formulierungen
DE69435033T2 (de) Parathormonarzneizusammensetzung
DE3689909T2 (de) Verwendung eines GHL-Cu enthaltenden Stoffes zur Herstellung eines Arzneimittels für Wunden.
DE69232064T2 (de) Peptide als Amylin-Agonisten und ihre Verwendung
EP0357978B1 (de) Pharmazeutische Zubereitung zur Behandlung des Diabetes mellitus
DE69125394T2 (de) Behandlung von osteoporose unter verwendung von wachstumshormon-freisetzendem faktor (grf) in verbindung mit parathyroidhormon (pth)
DE2415101A1 (de) Pharmazeutische zusammensetzungen
DE69827357T2 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DE2217817A1 (OSRAM)
CH683749A5 (de) Pharmazeutische Nasalzusammensetzung.
EP0065747A1 (de) Nonapeptid zur Behandlung von Suchtmittelentzugserscheinungen
DE3617728A1 (de) Feste nasale einsaetze, welche einen pharmakologisch akitven wirkstoff enthalten
EP0500602A1 (de) Mittel zur neutralisierung der tumorzellen-assoziierten prokoagulant-aktivität.
DE69024053T2 (de) Behandlung zur ermässigung von ödem und muskelschäden.
EP0185210A2 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE69000640T2 (de) Stabilisierte kalcitoninzubereitung.
DE69417397T2 (de) Lösung, die igf-1 enthält
DE10139410A1 (de) Verwendung von BIBN4096 in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne
DE2202176A1 (de) Komplexe von biologisch aktiven natuerlichen oder synthetischen Peptiden und/oder Polypeptiden und/oder Eiweissstoffen und/oder deren Derivaten bzw. Salzen,pharmazeutische Praeparate mit einem Gehalt an diesen und Verfahren zur Herstellung derselben
DE69837159T2 (de) Verfahren zur herstellung einer einzeldosisspritze mit lyophilisierter proteinmischung zur verabreichung eines volumens von weniger als 0,5 ml
DE69726281T2 (de) Hemmstoff für die gefässneubildung, der den gewebefaktor-inhibitor (tfpi) enthält
Drachman et al. Regeneration in botulinum-poisoned forelimbs of the newt, Triturus
DE69231263T2 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen
DE2710728A1 (de) Reagens fuer die radiologische abtastung von organen, verfahren zu seiner herstellung und seine verwendung
DE2616462A1 (de) Polypeptidhaltige pharmazeutische zubereitungen